Skip to content

Caesarean Wound Dressing Removal Study

A Randomised Controlled Trial on the Timing of Wound Dressing Removal After Emergency Caesarean Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05458518
Acronym
Cesarean
Enrollment
294
Registered
2022-07-14
Start date
2022-08-01
Completion date
2024-12-31
Last updated
2025-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Surgical Wound, Surgical Wound Infection

Keywords

wound dressing, cesarean

Brief summary

An open labelled randomised trial on the timing of wound dressing removal for emergency caesarean delivery in labour.

Detailed description

The trial is unblinded randomised trial on surgical wound dressing at 24 versus 48 hours after the emergency caesarean delivery in labour. The primary outcome is the prevalence of wound complications (hematoma, seroma, infection/ dehiscence) The secondary objectives are the maximum pain after the surgery (in ward) and the timing of the patient's first bath after the surgery

Interventions

PROCEDURECesarean wound dressing removal

The cesarean wound dressing is to be removed and the surgical wound exposed

Sponsors

Hospital Kemaman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 18-50 2. Lower segment caesarean delivery 3. Primary or repeat caesarean delivery 4. Caesarean section in active phase of labour. 5. Regional anaesthesia

Exclusion criteria

1. Upper segment or classical caesarean delivery 2. Massive postpartum haemorrhage \> 1.5 litre 3. Pre-delivery chorioamnionitis 4. Skin closure using interrupted suture 5. Acquired or congenital coagulation disorder 6. Associated medical or obstetric condition requiring prolonged hospital stay after delivery such as severe pre-eclampsia, uncontrolled diabetes mellitus, cardiac disease, systemic infection. 7. Inability to give consent

Design outcomes

Primary

MeasureTime frameDescription
Cesarean wound complication30 daysHematoma, seroma, wound infection, wound dehiscence

Secondary

MeasureTime frameDescription
Pain control48 hoursPerceived pain after caesarean according to Visual Analogue Scale (0/10 = no pain; 10/10 = worst pain)
Self hygiene48 hoursTiming of first bath after surgery

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026